Bayawa, Peter .

HRN: 26-16-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/02/2024
11/08/2024
IV
600MG
Q6
DM FOOT
Waiting Final Action 
11/02/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/02/2024
11/02/2024
IV
4.5g
Now
Nonhealing Wound, R Foot
Waiting Final Action 
11/02/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/02/2024
11/09/2024
IV
2.25g
Q6h
Nonhealing Wound, R Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: